Zynex, Inc. (ZYXI) Tops Q4 EPS by 1c, Revenues Beat; Offers Q1 & FY20 Revenue Guidance Above Consensus

Go back to Zynex, Inc. (ZYXI) Tops Q4 EPS by 1c, Revenues Beat; Offers Q1 & FY20 Revenue Guidance Above Consensus

Zynex, Inc. (ZYXI) Granted FDA Clearance for Blood Volume Monitor

February 25, 2020 9:13 AM EST

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical... More